Skip to content
HowShorted

BioXcel Therapeutics, Inc. short interest in 2026

In 2026, BioXcel Therapeutics, Inc.'s disclosed short interest ran from 6.25% of shares outstanding on 15 Jan 2026 to 14.94% on 15 Jul 2026, a change of +8.69 percentage points. The year's high was 15.94% on 15 Jun 2026 and its low 6.25% on 15 Jan 2026, averaging 12.04% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.46 days on 27 Feb 2026. Full history: BioXcel Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for BioXcel Therapeutics, Inc. in 2026

2026 in figures

Start of year
6.25% (15 Jan 2026)
End of year
14.94% (15 Jul 2026)
Change
+8.69 pp
High
15.94% (15 Jun 2026)
Low
6.25% (15 Jan 2026)
Average
12.04%
Highest days to cover
7.46 (27 Feb 2026)

Every report in 2026

BioXcel Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20266.25%1.91
30 Jan 20266.98%2.71
13 Feb 20268.86%5.61
27 Feb 20268.58%7.46
13 Mar 202612.83%1.00
31 Mar 202612.23%4.58
15 Apr 202614.58%3.08
30 Apr 202615.67%4.78
15 May 202613.13%5.66
29 May 202613.02%4.47
15 Jun 202615.94%6.85
30 Jun 202613.53%5.92
15 Jul 202614.94%1.64

See also: BioXcel Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.